Close Menu

strand sequencing

By Julia Karow
This article was originally published Feb.1.

The company, which won a four-year, $4.3 million grant from the National Human Genome Research Institute this fall, is working toward a nanopore strand sequencing technology that builds on an ion channel measurement platform it has been developing.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.